Fact CheckerSign in

NCT02154568Completed

Study of Airflow in the Lungs Using Helium MRI

Flow Quantification in the Human Airways Using Hyperpolarized Helium 3 MRI

Source: ClinicalTrials.gov · Last updated 17 Mar 2026

Brief summary (registry, in English)

Computer simulations are being developed to predict air flow abnormalities in the airways of patients with lung disease. The purpose of this study is to obtain actual gas flow measurements in the lungs of healthy patients and patients with lung disease and use these measurements to validate the computer models.

Status (registry)
Completed
Study type
Interventional
Enrollment
24 (actual)
First submitted
30 May 2014
Start date
7 Nov 2013
Primary completion date
26 Feb 2026
Lead sponsor
University of Virginia
Diseases
COPD
NCT number
NCT02154568

What you commit to

  • Study type: Interventional
  • Participants enrolled: 24
  • From 7 Nov 2013 to the primary completion date, 26 Feb 2026
  • 2 sites in 1 country
  • Visits and tests: ask the trial team, the registry does not list them

Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.

Who cannot take part

Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.

Prior treatment

  • Pregnancy, by report of subject. Clinically in the Department of radiology at UVA, self report is used when screening patients for MR scans as well as CT scans and fluoroscopy studies. If the subject reports there is any chance of their being pregnant a urine pregnancy test will be performed prior to any imaging.

Other illness

  • Any condition for which a MRI procedure is contraindicated.

Other

  • Presence of any non-MRI compatible metallic material in the body, such as pacemakers, metallic clips, etc.
  • Likelihood of claustrophobia
  • Chest circumference greater than that of the helium MR coil.

Who the study is looking for

  • Healthy subjects:
    • Normal PFT values: FEV1 \> 90% predicted; and Forced vital capacity (FVC) \> 90% predicted
    • Normal chest x-ray (CXR)
    • Medical history: No active pulmonary symptoms (cough, shortness of breath, sputum); Negative history of pulmonary disease; Negative smoking history (never smoked)
  • Pulmonary Disease Subjects:
    • PFT values: FEV1/FVC \< 70% (indicative of obstruction); and 30% \< FEV1 \< 50% predicted
    • CXR normal except hyperinflation
    • Symptoms - chronic shortness of breath
  • All test subjects, healthy and with COPD should have similar physical anthropometric characteristics:
    • Similar age with age difference less than 3 years
    • Similar height (within 3-4 inches)

Age in the registry: 18 years to - · Sex: All · Accepts healthy volunteers

Full criteria on ClinicalTrials.gov

Sites (2)

Sites in registry order. Pick your city on the disease page to sort them by distance.

SiteCityCountrySite status
University of Virginia Health System
Coordinator of this site? Confirm its status
CharlottesvilleUnited StatesUnknown status
Snyder Translation Fontaine Research Center 480 Ray C. Hunt Drive
Coordinator of this site? Confirm its status
CharlottesvilleUnited StatesUnknown status

This page is information, not medical advice. Discuss any trial with your doctor.